Particle.news

Download on the App Store

AI Model Sybil Validated for Lung Cancer Risk Prediction in Diverse Populations

Presented at the ATS 2025 International Conference, Sybil demonstrates high accuracy in forecasting lung cancer risk using a single low-dose CT scan, paving the way for prospective clinical trials.

Image

Overview

  • Sybil, a deep learning model developed by MIT and Harvard researchers, predicts lung cancer risk from a single low-dose CT scan without relying on demographic factors.
  • Validation results from over 21,000 individuals in South Korea show Sybil achieved 86% accuracy at one year and 74% at six years overall, with similar performance in never-smokers.
  • The model addresses rising lung cancer rates in nonsmokers, particularly in Asia, where current screening guidelines do not include low-risk groups.
  • Researchers aim to conduct prospective clinical trials to confirm Sybil’s clinical utility and expand its capabilities to predict outcomes like lung cancer-specific mortality.
  • Sybil’s ability to identify both low-risk individuals and those requiring closer monitoring could transform personalized lung cancer screening strategies globally.